Contrast Media: Comprehensive Notes (Bullet-Point Summary)

Contrast Media Notes

• This document compiles key ideas, concepts, indications, contraindications, and practical details about contrast media (CM) across X-ray, CT, MRI, and ultrasound imaging modalities.

• Goals of understanding CM include definitions, types, properties, indications, contraindications, side effects, and routes of administration.

• The material covers iodinated CM (including ionic vs non-ionic and osmolality differences), MRI CM (gadolinium-based), and ultrasonic CM (microbubbles), plus general concepts like double contrast and mode of administration.

Contrast Media: Overview

• A contrast medium (CM) is a substance used to enhance the contrast of structures or fluids within the body for medical imaging.

• CM helps differentiate anatomy and pathology by altering x-ray attenuation, magnetic properties, or echogenicity depending on modality.

Objectives

• Define contrast media (CM).

• Identify the different types of CM.

• Describe characteristics and properties of CM.

• Enumerate indications, contraindications, and side effects of CM.

• Identify different modes of administration.

Types of Contrast Media

• Positive contrast media

• Negative contrast media

• Double contrast media

• MRI contrast media

• Ultrasonic contrast media

Positive Contrast Media

• Characteristics:

  • High atomic number (high Z) substances that absorb x-rays more strongly than surrounding tissues.

  • Radiopaque (appears white on radiographs).

• Common positive CM examples (ibatible in clinical use):

  • Barium sulfate (BaSO4) — widely used, radiopaque.

  • Iodinated contrast media (ICM) — iodine-containing compounds used for IV/intravascular administration and imaging.

• Brand/components commonly listed (examples from the transcript):

  • Beilu iodinated agents (Beilu)

  • Gadopentetate dimeglumine injection

  • Iodixanol (Visipaque) injection

  • Iopamidol injection

  • Iohexol injection

• Administration notes:

  • Some agents are for intravenous administration only (e.g., certain iodinated agents).

  • Some are for intravascular use only with specified volumes (e.g., 15 mL, 100 mL, 50 mL doses listed).

Positive CM: Specific Agents (Iodinated CM) and Details

• BARIUM SULFATE (BaSO4) — high atomic number; alkaline earth metal; powder and liquid forms; powder+liquid forms available.

• IODINATED CM (IODINATED CONTRAST MEDIA):

  • Ionic vs Non-ionic distinction:

  • Ionic contrast agents are typically high osmolality.

  • Non-ionic contrast agents are low osmolality and have lower risk of complications.

  • Categories:

  • Ionic (high osmolality, higher risk): example agents include diatrizoate sodium (Hypaque), iothalamate meglumine (Conray).

  • Non-ionic (low osmolality, lower risk): iohexol (Omnipaque), iodixanol (Visipaque), iopamidol (Isovue), iopromide (Ultravist), ioversol (Optiray).

  • Osmolality differences (illustrative values):

  • High osmolality ionic agents: ext{Osmolality}
    ightarrow ext{around } 1500-2100

  • Low osmolality non-ionic agents: ext{Osmolality}
    ightarrow ext{around } 290-800 (range depending on agent)

  • Iodine content examples (illustrative from product inserts):

  • Iopamidol (Isovue) ~370 ext{ mgI/mL}

  • Iohexol (Omnipaque) ~300-350 ext{ mgI/mL}

  • Ioversol (Optiray) ~300-320 ext{ mgI/mL}

  • Ioxaglate (Hexabrix) ~320 ext{ mgI/mL} (note: Hexabrix is a dimer)

  • Iodixanol (Visipaque) ~320 ext{ mgI/mL} (dimer; isosmolar)

  • Diatrizoate (Hypaque) ~300 ext{ mgI/mL}

  • Isopaque (Isopaque 370) ~370 ext{ mgI/mL}

  • Example products listed in the transcript:

  • Hypaque, Gastrografin (diatrizoate) — ionic, high osmolality

  • Isopaque 370 — iothalamate, ionic, high osmolality

  • Conray — iothalamate meglumine, ionic, high osmolality

  • Hexabrix 320 — ioxaglate, ionic/dimer, moderate osmolality

  • Omnipaque 350/300 — iohexol, non-ionic, low/osmolarity near isotonic

  • Ultravist 370 — iopromide, non-ionic, low osmolality

  • Visipaque 320 — iodixanol, non-ionic, isosmolar

  • Isovue 370 — iopamidol, non-ionic, low osmolality

• Note on administration: Some agents are designated for intravenous administration or intravascular use only, with specific volume instructions.

Osmolality and Safety Considerations

• Ionic CM characteristics:

  • High osmolality, greater risk of complications; dissociate into separate ions in solution → hypertonic condition → increased plasma osmolality.

• Non-ionic CM characteristics:

  • Do not dissociate; remain near isotonic; no significant increase in osmolality.

• Practical safety note: Higher osmolality CM is associated with higher risk of adverse reactions, particularly in sensitive patients (e.g., those with kidney disease, heart disease).

Indications and Contraindications of Iodinated Contrast Media (ICM)

• Indications (common examples from the transcript):

  • Angiographic procedures

  • CT scans of brain, chest, abdomen

  • Intracranial imaging (IOC)

  • Urography

  • Esophagography, Upper GI series (UGIS), and SBIs (sialography?) references in the transcript)

• Contraindications (typical/allergy related and disease considerations):

  • Allergy or asthma to CM

  • Hypertension or blood pressure abnormalities

  • Cardiovascular diseases

  • Elevated creatinine (renal impairment)

  • Diabetes, dehydration

• Special instructions with medications: Metformin interaction

  • If a patient on metformin undergoes IV CM administration, there is an increased risk of lactic acidosis in those with decreased kidney function.

  • Recommendation: assess kidney function and consider hold/metformin status per guidelines (metformin contraindication in some contrast scenarios).

Ionic CM vs Non-ionic CM: Practical Effects

• Ionic CM (high osmolality):

  • Dissociates into ions; creates hypertonic state; increases osmolality.

• Non-ionic CM (low osmolality):

  • Does not dissociate; remains near isotonic; minimal impact on osmolality.

• Clinical implications:

  • Non-ionic CM generally better tolerated with fewer adverse reactions, especially in high-risk patients.

Other Forms and Preparations of CM

• Powder contrast (tablet form): Biloptin, Cistobil (example names).

• Oily contrast media: Myodil, Dinosil, Lipidol (historical/older formulations).

• Water-soluble CM: Often with sugar addition or other excipients to improve solubility.

• Physical forms:

  • Powder (tablet)

  • Oil-based

  • Water-soluble (aqueous) forms

Indications and Contraindications: Iodinated CM (Recap)

• Indications:

  • Angiography

  • CT scans (brain, chest, abdomen)

  • Urography

  • Esophagography and other contrast studies depending on protocol

• Contraindications:

  • Allergy/ asthma to CM

  • Hypertension or cardiovascular disease

  • Elevated creatinine or renal impairment

  • Diabetes/dehydration

Metformin Interaction with IV CM

• Potential risk: IV CM can increase the risk of lactic acidosis in patients with decreased kidney function who are taking metformin.

• Practical guidance: screen renal function; consider holding metformin as per institutional protocol when planning IV CM studies.

Iodinated CM Agents: Common Iodinated Contrast Media (Ionic vs Non-ionic) with Examples

• Ionic (high osmolality; higher risk):

  • Diatrizoate sodium (Hypaque)

  • Iothalamate meglumine (Conray)

  • Metrizoate (Isopaque) — high osmolality

• Non-ionic (low osmolality; lower risk):

  • Iohexol (Omnipaque)

  • Iodixanol (Visipaque)

  • Iopamidol (Isovue)

  • Iopromide (Ultravist)

  • Ioversol (Optiray)

• Illustrative iodine content and osmolality from product listings (approximate values):

  • Iopamidol (Isovue) — 370 ext{ mgI/mL}; Osmolality ext{ around } 796 (low osmolality category depends on specific product)

  • Iohexol (Omnipaque) — 350-350 ext{ mgI/mL}; Osmolality ext{ around } 884

  • Ioxilan (Oxilan) — 350 ext{ mgI/mL}; Osmolality ext{ around } 695

  • Iopromide (Ultravist) — 370 ext{ mgI/mL}; Osmolality ext{ around } 774

  • Iodixanol (Visipaque) — 320 ext{ mgI/mL}; Osmolality ext{ around } 290 (isotonic)

  • Ioversol (Optiray) — 300 ext{ mgI/mL}; Osmolality ext{ around } ~ ext{low})

  • Hexabrix (iopromide/ioxaglate?; actually ioxaglate) — 320 ext{ mgI/mL}; Osmolality ext{ around } 580

• Product insert notes (examples):

  • Omnipaque (iohexol) 300 mg/mL; Visipaque (iodixanol) 320 mg/mL; Ultravist (iopromide) 370 mg/mL; Isovue (iopamidol) 370 mg/mL; Hypaque (diatrizoate) 50/ Gastrografin; Conray (iothalamate meglumine) 370 mgI/mL; Hexabrix 320 (ioxaglate) 320 mgI/mL.

• Storage/handling notes from inserts (illustrative):

  • Some products require storage at specific temperatures; keep out of light; discard unused portions after single-use; follow packaging directions.

MRI Contrast Media (Paramagnetic CM)

• Agent type: Gadolinium-based contrast agents (GBCAs) — Paramagnetic.

• Common gadolinium-based agents listed in the transcript:

  • Gadobenic acid

  • Gadobutrol

  • Gadodiamide

  • Gadofosveset

  • Gadopentetic acid

  • Gadoteric acid

  • Gadoteridol

  • Gadoversetamide

  • Gadoxetic acid

• Example product: Gadovist (gadobutrol) — reference to Bayer packaging with dosage information; standard dose around 0.1 mmol/kg for MRI in adults; packaging details include 1.0 mmol/ mL solutions and poly bottle formats.

• Indications (typical):

  • Imaging tumors, cysts, metastases (CA or mets)

  • Cerebrovascular events (CVA or TIA)

  • Arterial stenosis assessment

• Contraindications (typical):

  • Allergies/asthma to gadolinium-based agents

  • Severe renal impairment or conditions predisposing to nephrogenic systemic fibrosis (NSSF) risk considerations; check current guidelines.

• Notable safety notes:

  • Gadolinium-based agents are used with caution in patients with kidney dysfunction or dialysis-dependent patients; ensure appropriate risk-benefit analysis.

Ultrasound Contrast Media

• Types:

  • Microbubbles

  • Microspheres of protein

  • Microspheres with outer lipid shell (e.g., Albunex, Definity, Sonovue)

  • Gases used: sulfur hexafluoride (SF6), perflutren; perflubutane (Sonozoid) etc.

• Common agents mentioned: Albunex, Levovist, Definity (perflutren), SonoVue (sulfur hexafluoride), Sonovue (sulfur hexafluoride gas), Sonozoid (perflorobutane gas).

• Indications for ultrasound contrast use (examples from the transcript):

  • Visualization of endocardium

  • Apical hypertrophic cardiomyopathy assessment

  • Intracavitary thrombi visualization

  • LV apex clarity (visualization of LV apex)

  • LV aneurysms and pseudoaneurysms

• Contraindications listed in the transcript:

  • Right-to-left shunts

  • Unstable coronary syndrome

  • Congestive heart failure

  • Severe pulmonary hypertension

  • Use with dobutamine (if indicated by protocol)

• Administration notes:

  • SonoVue is supplied as a powder for dispersion; reconstituted for injection at approximately 8 microliters/mL and delivered per protocol.

• Safety and side effects:

  • Expected side effects include warmth, flushing, metallic taste.

  • Moderate adverse reactions: tachycardia or bradycardia, hypertension or hypotension, dyspnea, bronchospasm or wheezing, laryngeal edema.

  • Severe reactions: dyspnea with laryngeal edema, hypotension, seizures, cardiac arrhythmias, lack of patient response, cardiac arrest.

Mode of Contrast Administration

• Enteral options:

  • PO (oral)

  • Rectal

• Parenteral options:

  • Intravenous (IV)

  • Intra-arterial

  • Intrathecal

• Practical notes:

  • Some CM are suited for oral or rectal administration depending on the clinical question and imaging modality.

Modes of Contrast Administration: Practical Overview

• Enteral administration: PO or rectal CM used for GI tract imaging or preparation in certain protocols.

• Parenteral administration: intravascular routes (IV, intra-arterial) for CT, MRI, or angiographic studies.

• Notation: The transcript lists specific routes for various agents (e.g., some iodinated CM are for intravenous administration only; others may be intravascular or oral).

Relationship to Other Imaging Modalities

• Radiography/CT:

  • Positive CM (iodinated CM) and negative CM (air, CO2) are used depending on the study protocol.

  • Double contrast studies combine positive and negative CM (e.g., esophagography, UGI, CT abdomen, arthrography).

• MRI:

  • MRI CM are gadolinium-based (paramagnetic) agents; used to enhance lesion delineation, tumor characterization, vascular imaging, and detecting CVA/TIA and arterial stenosis.

• Ultrasound:

  • Ultrasound CM are microbubble-based or gas-filled spheres that enhance echogenicity and endocardial border visualization.

Double Contrast Media

• Definition: Combination of positive and negative contrast media to enhance visualization of a structure.

• Indications listed in the transcript include:

  • Esophagography

  • UGI (upper GI series)

  • BE (barium enema) and CT abdomen

  • Arthrography

Practical and Ethical/Clinical Implications

• Important considerations:

  • Allergies to CM must be screened prior to administration.

  • Renal function should be assessed before iodinated CM, particularly in patients at risk for nephrotoxicity or with diabetes/dehydration.

  • Metformin use requires consideration of contraindications or temporary hold during CM studies to reduce risk of lactic acidosis in patients with kidney impairment.

• Real-world relevance:

  • Choice between ionic vs non-ionic CM depends on patient risk factors, kidney function, and the imaging study’s diagnostic requirements.

  • MRI CM use must balance diagnostic benefit with potential nephrotoxicity and NSF risk considerations in susceptible populations.

  • Ultrasound CM can improve visualization of cardiac structures and intracavitary thrombi without ionizing radiation exposure.

Summary of Key Numerical Details and Specifications (Illustrative)

• Iodine content examples (typical):

  • 300 ext{ mgI/mL}, 370 ext{ mgI/mL}, 320 ext{ mgI/mL}, etc.

• Osmolality examples (illustrative ranges):

  • High osmolality ionic agents: around 1500-2100

  • Low osmolality non-ionic agents: around 290-800, depending on product

• MRI gadolinium-based agents: various agents listed (gadobenate, gadobutrol, gadodiamide, gadoversetamide, gadopentetate, gadoteridol, gadoxetic acid, etc.)

• Ultrasound contrast agents and microbubbles: dosing and administration vary by product and protocol; example products include Definity, SonoVue, Levovist, Albunex.

Quick Reference: Indications and Contraindications by Modality

• Iodinated CM (CT/angiography):

  • Indications: angiography, CT brain/chest/abdomen, urography, esophagography, UGI, etc.

  • Contraindications: allergy/asthma to CM, high BP or cardiovascular disease, elevated creatinine, dehydration/diabetes.

• MRI CM (Gadolinium-based):

  • Indications: tumor, cysts, metastases, CVA/TIA, arterial stenosis, etc.

  • Contraindications: allergy/asthma to gadolinium agents; caution in severe renal impairment; NSF risk.

• Ultrasound CM (Microbubbles):

  • Indications: endocardial visualization, LV apex assessment, intracavitary thrombi, aneurysm/pseudoaneurysm detection.

  • Contraindications: right-to-left shunts, unstable coronary syndrome, heart failure, severe pulmonary hypertension.

End of Notes